Gilead Sciences (GILD) Shares Bounce Higher Following HCV/NASH News

October 20, 2016 11:45 AM EDT

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Gilead Sciences (NASDAQ: GILD) shares are traveling higher following an initial pop on NASH and HCV development news. The stock is now up around 1 percent.

For the latest on Gilead, click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Trader Talk

Add Your Comment